Pharmacovigilance is becoming more complex as data sources expand, regulations tighten, and expertise gaps widen. To cope, two-thirds of life sciences companies now outsource PV operations, often to multiple vendors, with outsourcing forecasted to grow 7% annually through 2030. Survey data show strong interest in combined PV services and technology, which improve efficiency, simplify vendor management, and cut time to market. Barriers include cost concerns, miscommunication, and reliance on established vendors. Still, 89% plan to adopt combined PV solutions, citing operational efficiency, compliance, and faster regulatory response as key benefits.

Join for free to read